How a Target Safety Assessment Supports the Drug Development Process

Drug Discovery World Podcast

In the latest sponsored DDW Sitting Down With podcast Professor Ruth Roberts, Co-Founder ApconiX, and Claire Sadler, Project Toxicologist, discuss the benefits of carrying out a target safety assessment (TSA) during drug discovery and development whenever a biological target is going to be modulated.

The speakers outline how TSAs can be used throughout the drug discovery and development pathway and offer examples of best practice and potential next steps. Listen now.